Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg

Background. The influenza vaccination coverage has steadily increased in the Russian Federation. The introduction of new domestic influenza vaccines into practice and the study of their effectiveness are of great importance for public health. However, a systematic analysis of the effectiveness of va...

Full description

Saved in:
Bibliographic Details
Main Authors: M. K. Erofeeva, M. A. Stukova, E. V. Shakhlanskaya, Zh. V. Buzitskaya, V. L. Maksakova, T. I. Krainova, T. M. Chirkina, M. M. Pisareva, D. A. Lioznov
Format: Article
Language:Russian
Published: Numikom LLC 2020-11-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
Online Access:https://www.epidemvac.ru/jour/article/view/1088
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690017284227072
author M. K. Erofeeva
M. A. Stukova
E. V. Shakhlanskaya
Zh. V. Buzitskaya
V. L. Maksakova
T. I. Krainova
T. M. Chirkina
M. M. Pisareva
D. A. Lioznov
author_facet M. K. Erofeeva
M. A. Stukova
E. V. Shakhlanskaya
Zh. V. Buzitskaya
V. L. Maksakova
T. I. Krainova
T. M. Chirkina
M. M. Pisareva
D. A. Lioznov
author_sort M. K. Erofeeva
collection DOAJ
description Background. The influenza vaccination coverage has steadily increased in the Russian Federation. The introduction of new domestic influenza vaccines into practice and the study of their effectiveness are of great importance for public health. However, a systematic analysis of the effectiveness of vaccines manufactured and used in Russia in recent years has not been performed. The aim ofthe study was to assess the epidemiological effectiveness of three domestic influenza vaccines in St. Petersburg during the 2018–2019 epidemic season.Material and methods. The organized community of 1892 young students aged 18 to 23 years has been under supervision during the period of time from October 2018 to March 2019. Influenza vaccines Grippol Plus, Sovigripp, and Ultrix were used for vaccination.Results and discussion. Prophylactic vaccination with influenza vaccines Sovigripp, Grippol Plus and Ultrix in the fall of 2018 led to a decrease in the incidence of influenza and other acute respiratory infections (ARI) by a total of 1.6–3.8 times; a decrease in the incidence of influenza by 2.7–7.1 times; the total protective efficacy of vaccines against influenza and ARI was 52.4%, and against influenza, taking into account laboratory correction, 73.3%.Conclusions. Under the conditions of the viruses circulating in Russia and in St. Petersburg in the 2018–2019 epidemic season the strains introduced into the composition of influenza vaccines, domestic influenza vaccines were characterized by good tolerance, were safe, areactogenic and had a pronounced protective effect. If the viruses circulating in Russia and in St. Petersburg in the 2018–2019 epidemic season corresponded to the strains introduced into the composition of influenza vaccines, domestic influenza vaccines, showing good tolerance, safety and low reactogenicity, had a pronounced protective effect.
format Article
id doaj-art-2f0348b52c514557baff4bf9779c6729
institution DOAJ
issn 2073-3046
2619-0494
language Russian
publishDate 2020-11-01
publisher Numikom LLC
record_format Article
series Эпидемиология и вакцинопрофилактика
spelling doaj-art-2f0348b52c514557baff4bf9779c67292025-08-20T03:21:27ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942020-11-01195768310.31631/2073-3046-2020-19-5-76-83682Evaluation of the preventive effectiveness of influenza vaccines in St. PetersburgM. K. Erofeeva0M. A. Stukova1E. V. Shakhlanskaya2Zh. V. Buzitskaya3V. L. Maksakova4T. I. Krainova5T. M. Chirkina6M. M. Pisareva7D. A. Lioznov8Smorodintsev Research Influenza InstituteSmorodintsev Research Influenza InstituteSmorodintsev Research Influenza InstituteSmorodintsev Research Influenza InstituteSmorodintsev Research Influenza InstituteSmorodintsev Research Influenza InstituteNorth-Western State Medical University named after I.I. MechnikovSmorodintsev Research Influenza InstituteSmorodintsev Research Influenza Institute; St. Petersburg Pavlov State Medical UniversityBackground. The influenza vaccination coverage has steadily increased in the Russian Federation. The introduction of new domestic influenza vaccines into practice and the study of their effectiveness are of great importance for public health. However, a systematic analysis of the effectiveness of vaccines manufactured and used in Russia in recent years has not been performed. The aim ofthe study was to assess the epidemiological effectiveness of three domestic influenza vaccines in St. Petersburg during the 2018–2019 epidemic season.Material and methods. The organized community of 1892 young students aged 18 to 23 years has been under supervision during the period of time from October 2018 to March 2019. Influenza vaccines Grippol Plus, Sovigripp, and Ultrix were used for vaccination.Results and discussion. Prophylactic vaccination with influenza vaccines Sovigripp, Grippol Plus and Ultrix in the fall of 2018 led to a decrease in the incidence of influenza and other acute respiratory infections (ARI) by a total of 1.6–3.8 times; a decrease in the incidence of influenza by 2.7–7.1 times; the total protective efficacy of vaccines against influenza and ARI was 52.4%, and against influenza, taking into account laboratory correction, 73.3%.Conclusions. Under the conditions of the viruses circulating in Russia and in St. Petersburg in the 2018–2019 epidemic season the strains introduced into the composition of influenza vaccines, domestic influenza vaccines were characterized by good tolerance, were safe, areactogenic and had a pronounced protective effect. If the viruses circulating in Russia and in St. Petersburg in the 2018–2019 epidemic season corresponded to the strains introduced into the composition of influenza vaccines, domestic influenza vaccines, showing good tolerance, safety and low reactogenicity, had a pronounced protective effect.https://www.epidemvac.ru/jour/article/view/1088influenzaacute respiratory viral infectionsvaccinepreventioneffectivenessdiagnosispcr
spellingShingle M. K. Erofeeva
M. A. Stukova
E. V. Shakhlanskaya
Zh. V. Buzitskaya
V. L. Maksakova
T. I. Krainova
T. M. Chirkina
M. M. Pisareva
D. A. Lioznov
Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
Эпидемиология и вакцинопрофилактика
influenza
acute respiratory viral infections
vaccine
prevention
effectiveness
diagnosis
pcr
title Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
title_full Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
title_fullStr Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
title_full_unstemmed Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
title_short Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
title_sort evaluation of the preventive effectiveness of influenza vaccines in st petersburg
topic influenza
acute respiratory viral infections
vaccine
prevention
effectiveness
diagnosis
pcr
url https://www.epidemvac.ru/jour/article/view/1088
work_keys_str_mv AT mkerofeeva evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT mastukova evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT evshakhlanskaya evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT zhvbuzitskaya evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT vlmaksakova evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT tikrainova evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT tmchirkina evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT mmpisareva evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg
AT dalioznov evaluationofthepreventiveeffectivenessofinfluenzavaccinesinstpetersburg